Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Maternal antibodies against fetal blood group antigens A or B: lytic activity of IgG subclasses in monocyte-driven cytotoxicity and correlation with ABO haemolytic disease of the newborn.

Brouwers HA, Overbeeke MA, Ouwehand WH, Keuning K, van Ertbruggen I, van Leeuwen EF, Stoop JW, Engelfriet CP.

Br J Haematol. 1988 Dec;70(4):465-9.

PMID:
3219297
2.

Role of antibody dependent cell mediated cytotoxicity in ABO hemolytic disease of the newborn.

Patil JS, Gupte SC.

Indian J Pediatr. 1995 Sep-Oct;62(5):587-92.

PMID:
10829927
3.
4.

What is the best predictor of the severity of ABO-haemolytic disease of the newborn?

Brouwers HA, Overbeeke MA, van Ertbruggen I, Schaasberg W, Alsbach GP, van der Heiden C, van Leeuwen EF, Stoop JW, Engelfriet CP.

Lancet. 1988 Sep 17;2(8612):641-4.

PMID:
2901516
5.

Antibody-dependent cell-mediated destruction of human erythrocytes sensitized in ABO and rhesus fetal-maternal incompatibilities.

Zawodnik SA, Bonnard GD, Gautier AE, Macdonald HR.

Pediatr Res. 1976 Sep;10(9):791-6.

PMID:
822389
6.

Complement is not activated in ABO-haemolytic disease of the newborn.

Brouwers HA, Overbeeke MA, Huiskes E, Bos MJ, Ouwehand WH, Engelfriet CP.

Br J Haematol. 1988 Mar;68(3):363-6.

PMID:
3258530
7.

IgG subclasses of anti-A and anti-B antibodies bound to the cord red cells in ABO incompatible pregnancies.

Ukita M, Takahashi A, Nunotani T, Kihana T, Watanabe S, Yamada N.

Vox Sang. 1989;56(3):181-6.

PMID:
2728395
9.
10.

Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.

Dooren MC, van Kamp IL, Kanhai HH, Gravenhorst JB, von dem Borne AE, Engelfriet CP.

Vox Sang. 1993;65(1):55-8.

PMID:
8362515
11.

Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.

Garner SF, Gorick BD, Lai WY, Brown D, Taverner J, Hughes-Jones NC, Contreras M, Lubenko A.

Vox Sang. 1995;68(3):169-76.

PMID:
7625074
12.
13.

Haemolysis mediated by anti-D monoclonal antibodies in direct and cold target competition ADCC assays.

Bakács T, Kumpel BM, Tusnády G.

Immunol Lett. 1992 May;32(3):223-31.

PMID:
1500093
14.
15.

Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).

Dooren MC, Kuijpers RW, Joekes EC, Huiskes E, Goldschmeding R, Overbeeke MA, von dem Borne AE, Engelfriet CP, Ouwehand WH.

Lancet. 1992 May 2;339(8801):1067-70.

PMID:
1349101
16.

Three examples of Rh haemolytic disease of the newborn with a negative direct antiglobulin test.

Heddle NM, Wentworth P, Anderson DR, Emmerson D, Kelton JG, Blajchman MA.

Transfus Med. 1995 Jun;5(2):113-6.

PMID:
7655573
17.

Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.

Hadley AG.

Transpl Immunol. 2002 Aug;10(2-3):191-8. Review.

PMID:
12216949
18.

Sensitive methods for determining subclasses of IgG anti-A and anti-B in sera of blood-group-O women with a blood-group-A or -B child.

Brouwers HA, Overbeeke MA, Gemke RJ, Maas CJ, van Leeuwen EF, Engelfriet CP.

Br J Haematol. 1987 Jun;66(2):267-70.

PMID:
3300763
20.

Supplemental Content

Support Center